Investing.com -- Walgreens Boots Alliance (NASDAQ: WBA ) and its subsidiaries are set to pay $300 million to resolve allegations from the U.S. Justice Department. The pharmacy chain has been accused of unlawfully filling millions of invalid prescriptions for opioids and other controlled substances. This announcement was made by the Justice Department on Monday.

In addition to this settlement, Walgreens is obliged to pay an extra $50 million to the United States if the company undergoes a sale, merger, or transfer before the fiscal year 2032, according to the Justice Department’s statement.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.